HUNTINGTON DISEASE MUTATION ANALYSIS, EDTA BLOOD

image not found

NABL Cap Accredited      
This test detects genetic mutations in the HTT gene responsible for Huntington’s Disease, a progressive neurodegenerative disorder. It identifies expanded CAG repeats that cause the disease, enabling confirmation of diagnosis, predictive testing in at-risk individuals, and family counseling. The test is essential for clinical decision-making and planning long-term care. Metropolis Healthcare uses advanced molecular techniques to provide precise and reliable results for accurate genetic assessment

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,850.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: H0286

Frequently Asked Questions (FAQ's):

What does the Huntington Disease Mutation Analysis detect?
It identifies CAG repeat expansions in the HTT gene that cause Huntington’s Disease.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses molecular genetic techniques to precisely quantify CAG repeats in the HTT gene.

Who should consider this test?
Individuals with a family history of Huntington’s Disease, those showing neurological symptoms, or at-risk asymptomatic family members.

What type of sample is required?
EDTA blood collected via routine venipuncture.

Is fasting required before this test?
No fasting or special preparation is needed.

How are the results clinically useful?
They confirm diagnosis, support predictive testing, and guide genetic counseling and family planning.

How long does Metropolis Healthcare take to provide results?
Results are typically available within 2–3 weeks due to detailed genetic analysis.

Can family members be tested if a mutation is detected?
Yes, cascade testing and genetic counseling are recommended for at-risk relatives

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab